In the coming year, efficiency and automation will take center stage to maximize constrained resources but balancing sensible financial management with strategic investments will be vital.
Max Kelleher
Advertisement
Articles by Max Kelleher
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
2
Why CMS Is Tightening ASP Reporting and What Manufacturers Must Get Right
3
Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines
4
Quotient Therapeutics Enters Research Collaboration with Merck to Discover Drug Targets in Inflammatory Bowel Disease
5